SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-21-002097
Filing Date
2021-06-17
Accepted
2021-06-17 09:11:15
Documents
5
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 6-K zk2126199.htm 6-K 350503
2 image00001.jpg GRAPHIC 5367
3 image00002.jpg GRAPHIC 1486
4 image00003.jpg GRAPHIC 1756
5 image00004.jpg GRAPHIC 4044
  Complete submission text file 0001178913-21-002097.txt   369361
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 211023477
SIC: 2834 Pharmaceutical Preparations